The ASGCT 2025 Advancing Cell & Gene Therapies for Cancer symposium highlighted major progress in integrating oncolytic virotherapy, cellular immunotherapy, epigenetic and metabolic reprogramming of the tumor immune microenvironment, and synthetic gene engineering.
A post-meeting report titled “2025 Advancing Cell and Gene Therapies for Cancer” has been published, highlighting key discussions and emerging directions from the meeting.
The report, authored by Paola Grandi, Maria G. Castro, Evanthia Galanis, Michael C. Milone, and Saad Kenderian, summarizes major advances in cell and gene therapy approaches for cancer treatment, including translational strategies, clinical applications, and future therapeutic opportunities. This collaborative report reflects the growing momentum in the field and underscores the importance of interdisciplinary efforts to accelerate the development of next-generation cancer therapies.